Inhibitors of PI3Kβ as Potential Treatment for Cancer

被引：1
|
作者：
Abdel-Magid, Ahmed F. [1 ]
机构：
[1] Therachem Res Medilab India Pvt Ltd, Jaipur, Rajasthan, India
来源：
ACS MEDICINAL CHEMISTRY LETTERS | 2013年 / 4卷 / 09期
关键词：
D O I：
10.1021/ml400274v
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
引用
收藏
页码：815 / 816
页数：2
相关论文
共 50 条
  • [1] Potential role of PI3K inhibitors in the treatment of breast cancer
    Carvalho, Silvia
    Schmitt, Fernando
    FUTURE ONCOLOGY, 2010, 6 (08) : 1251 - 1263
  • [2] Exploring the potential of PI3K inhibitors for inflammation and cancer
    Crabbe, T.
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2007, 35 : 253 - 256
  • [3] Inhibition of PI3K as a potential treatment for cancer
    Zuluaga, S.
    Suarez-Fueyo, A.
    Carrera, A. C.
    EJC SUPPLEMENTS, 2010, 8 (05): : 61 - 61
  • [4] Potential Value and Limitation of Dual Inhibitors of PI3K and mTOR in the Treatment of Cancer
    Chen, Jiezhong
    CURRENT CANCER DRUG TARGETS, 2013, 13 (02) : 117 - 120
  • [5] Bringing PI3K Delta Inhibitors to Cancer Treatment
    不详
    CANCER DISCOVERY, 2011, 1 (01) : OF4 - OF4
  • [6] Identification of novel potential PI3Kα inhibitors for cancer therapy
    Zhang, Qingyan
    Sang, Feng
    Qian, Jieyu
    Lyu, ShaoLi
    Wang, Wang
    Wang, Ying
    Li, Qiang
    Du, LinFang
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2021, 39 (10): : 3721 - 3732
  • [7] The Impact of PI3K Inhibitors for the Treatment of Patients with Breast Cancer
    Traina, Tiffany A.
    ONCOLOGY-NEW YORK, 2020, 34 (01): : 28 - 31
  • [8] Design, synthesis, and biological evaluation of novel bivalent PI3K inhibitors for the potential treatment of cancer
    Xia, Liang
    Jiang, Lin
    Du, Tingting
    Lin, Songwen
    Xiong, Tianning
    Peng, Shouguo
    Tian, Hua
    Zhang, Kehui
    Wu, Deyu
    Sheng, Li
    Ji, Ming
    Chen, Xiaoguang
    Xu, Heng
    BIOORGANIC CHEMISTRY, 2023, 140
  • [9] PI3K inhibitors in inflammation, autoimmunity and cancer
    Stark, Anne-Katrien
    Sriskantharajah, Srividya
    Hessel, Edith M.
    Okkenhaug, Klaus
    CURRENT OPINION IN PHARMACOLOGY, 2015, 23 : 82 - 91
  • [10] Development and safety of PI3K inhibitors in cancer
    Miaomiao Yu
    Jiajia Chen
    Zhifei Xu
    Bo Yang
    Qiaojun He
    Peihua Luo
    Hao Yan
    Xiaochun Yang
    Archives of Toxicology, 2023, 97 : 635 - 650
12345